Stocks Overview

LAST PRICE
71.7200
TODAY'S CHANGE (%)
Trending Up1.3300 (1.8895%)

Bid / Lots
71.7200/ 5
Ask / Lots
72.0100/ 5
Open / Previous Close
70.4300 / 70.3900
Day Range
Low 70.3300
High 72.0000
52 Week Range
Low 50.3498
High 83.9500
Volume
1,521,881
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 70.39
Time	Volume	INCY
09:32 ET	9850	70.355
09:33 ET	4515	70.49
09:35 ET	3274	70.63
09:37 ET	4237	70.44
09:39 ET	1446	70.62
09:42 ET	1450	70.965
09:44 ET	700	70.86
09:46 ET	4700	71.16
09:48 ET	4139	70.955
09:50 ET	2027	70.915
09:51 ET	3803	70.99
09:53 ET	2923	70.965
09:55 ET	1946	71.02
09:57 ET	1533	71.13
10:00 ET	1485	71.25
10:02 ET	1548	71.255
10:04 ET	24119	71.045
10:06 ET	1300	70.82
10:08 ET	5995	70.92
10:09 ET	1200	71.14
10:11 ET	1400	71.17
10:13 ET	1046	71.125
10:15 ET	870	71.32
10:18 ET	905	71.395
10:20 ET	981	71.37
10:22 ET	1767	71.285
10:24 ET	625	71.23
10:26 ET	815	71.23
10:27 ET	2198	71.14
10:29 ET	1966	70.96
10:31 ET	1134	70.96
10:33 ET	200	71.015
10:36 ET	4639	71.185
10:38 ET	3000	71.08
10:40 ET	1600	71.07
10:42 ET	9025	70.98
10:44 ET	500	70.97
10:45 ET	623	70.985
10:47 ET	700	70.925
10:49 ET	420	70.905
10:51 ET	1100	70.98
10:54 ET	2150	71.03
10:56 ET	2189	71.02
10:58 ET	3365	71.17
11:00 ET	4200	71.3
11:02 ET	1918	71.41
11:03 ET	400	71.405
11:05 ET	2900	71.27
11:07 ET	800	71.28
11:09 ET	3125	71.455
11:12 ET	5121	71.61
11:14 ET	10521	71.6
11:16 ET	1600	71.685
11:18 ET	2548	71.66
11:20 ET	200	71.67
11:21 ET	2435	71.58
11:23 ET	4366	71.72
11:25 ET	900	71.77
11:27 ET	1222	71.88
11:30 ET	12861	71.765
11:32 ET	3215	71.68
11:34 ET	2434	71.615
11:36 ET	1973	71.735
11:38 ET	816	71.79
11:39 ET	920	71.92
11:41 ET	5067	71.89
11:43 ET	1000	71.83
11:45 ET	1230	71.87
11:48 ET	1850	71.91
11:50 ET	8431	71.82
11:52 ET	12660	71.68
11:54 ET	2417	71.735
11:56 ET	4947	71.78
11:57 ET	600	71.74
11:59 ET	3577	71.73
12:01 ET	4740	71.72
12:03 ET	914	71.75
12:06 ET	1300	71.76
12:08 ET	200	71.8
12:10 ET	1000	71.76
12:12 ET	100	71.745
12:14 ET	2100	71.76
12:15 ET	700	71.74
12:17 ET	1800	71.73
12:19 ET	719	71.64
12:21 ET	900	71.64
12:24 ET	1327	71.635
12:26 ET	500	71.67
12:28 ET	601	71.68
12:30 ET	892	71.6211
12:32 ET	2222	71.465
12:33 ET	2450	71.445
12:35 ET	4246	71.535
12:37 ET	500	71.51
12:39 ET	900	71.54
12:42 ET	1620	71.56
12:44 ET	1000	71.6
12:46 ET	16300	71.59
12:48 ET	408	71.53
12:50 ET	851	71.61
12:51 ET	4300	71.58
12:53 ET	509	71.55
12:55 ET	1000	71.57
12:57 ET	400	71.63
01:00 ET	1200	71.63
01:02 ET	2200	71.56
01:04 ET	1400	71.56
01:06 ET	800	71.58
01:08 ET	1854	71.49
01:09 ET	1714	71.635
01:11 ET	1400	71.59
01:13 ET	1700	71.64
01:15 ET	1400	71.68
01:18 ET	2772	71.63
01:20 ET	905	71.61
01:22 ET	600	71.67
01:24 ET	1400	71.7
01:26 ET	600	71.71
01:27 ET	3100	71.59
01:29 ET	1900	71.59
01:31 ET	1407	71.61
01:33 ET	1300	71.59
01:36 ET	12496	71.52
01:38 ET	2400	71.46
01:40 ET	1200	71.44
01:42 ET	2174	71.4799
01:44 ET	500	71.45
01:45 ET	400	71.42
01:47 ET	2400	71.515
01:49 ET	3444	71.45
01:51 ET	2000	71.43
01:54 ET	1510	71.43
01:56 ET	700	71.39
01:58 ET	7514	71.38
02:00 ET	1608	71.36
02:02 ET	1155	71.345
02:03 ET	3091	71.39
02:05 ET	2680	71.505
02:07 ET	1664	71.45
02:09 ET	1500	71.44
02:12 ET	3849	71.53
02:14 ET	1100	71.485
02:16 ET	1281	71.475
02:18 ET	1160	71.48
02:20 ET	600	71.515
02:21 ET	600	71.52
02:23 ET	1100	71.545
02:25 ET	1200	71.51
02:27 ET	1322	71.52
02:30 ET	2600	71.454
02:32 ET	300	71.485
02:34 ET	2234	71.49
02:36 ET	1961	71.48
02:38 ET	1320	71.525
02:39 ET	2336	71.481
02:41 ET	1321	71.49
02:43 ET	1290	71.485
02:45 ET	2650	71.52
02:48 ET	4100	71.495
02:50 ET	1924	71.53
02:52 ET	1970	71.52
02:54 ET	2081	71.48
02:56 ET	1181	71.47
02:57 ET	1159	71.47
02:59 ET	1753	71.45
03:01 ET	1127	71.45
03:03 ET	2121	71.42
03:06 ET	2908	71.41
03:08 ET	713	71.48
03:10 ET	1340	71.41
03:12 ET	4215	71.57
03:14 ET	3378	71.655
03:15 ET	1831	71.61
03:17 ET	2240	71.59
03:19 ET	1490	71.58
03:21 ET	5295	71.55
03:24 ET	1828	71.6
03:26 ET	6561	71.44
03:28 ET	1500	71.38
03:30 ET	2550	71.43
03:32 ET	48804	71.237
03:33 ET	6876	71.29
03:35 ET	10676	71.2975
03:37 ET	7421	71.24
03:39 ET	40457	71.06
03:42 ET	16984	70.97
03:44 ET	6759	70.975
03:46 ET	5781	70.98
03:48 ET	8436	71.155
03:50 ET	4417	71.26
03:51 ET	4411	71.26
03:53 ET	6943	71.5
03:55 ET	15093	71.65
03:57 ET	17178	71.67
04:00 ET	401099	71.72

Data delayed at least 15 minutes.

Yesterday
- INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investment, from 7:31AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:31AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 19, 2024
- Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation, from 4:30PM ET on Tuesday Nov 19, 2024 by Dow Jones
  4:30PM ET on Tuesday Nov 19, 2024 by Dow Jones
- DJ Incyte Is the S&P 500's Worst Performer Today. What's Hitting the Stock. -- Barrons.com, from 12:21PM ET on Tuesday Nov 19, 2024 by Dow Jones
  12:21PM ET on Tuesday Nov 19, 2024 by Dow Jones
- DJ Incyte Is Maintained at Sector Perform by RBC Capital, from 10:52AM ET on Tuesday Nov 19, 2024 by Dow Jones
  10:52AM ET on Tuesday Nov 19, 2024 by Dow Jones
- DJ Incyte Down Over 10%, on Pace for Largest Percent Decrease Since April 2018 -- Data Talk, from 10:13AM ET on Tuesday Nov 19, 2024 by Dow Jones
  10:13AM ET on Tuesday Nov 19, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesINCY Incyte Corp	13.6B	512.5x	+39.11%
United StatesCRL Charles River Laboratories International Inc	9.9B	24.4x	+15.57%
United StatesBMRN BioMarin Pharmaceutical Inc	12.1B	38.6x	---
United StatesEXAS Exact Sciences Corp	9.8B	-45.1x	---
United StatesUTHR United Therapeutics Corp	16.4B	16.4x	+8.22%
United StatesNBIX Neurocrine Biosciences Inc	12.7B	33.6x	+62.04%
As of 2024-11-22

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib), ICLUSIG (ponatinib), and ZYNYZ (retifanlimab-dlwr), as well as numerous clinical development programs. The Company's pipeline also includes two first-in-class small molecule antagonists targeting Mas-related G protein-coupled receptor X2 (MRGPRX2) for the treatment of various mast cell mediated disorders and MRGPRX4 for cholestatic pruritus.

Contact Information

Headquarters: 1801 Augustine Cut-OffWILMINGTON, DE, United States 19803
Phone: 302-498-6700
Fax: 302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer: Herve Hoppenot
President and Head - Research and Development: Pablo Cagnoni
Chief Financial Officer, Executive Vice President: Christiana Stamoulis
Executive Vice President, General Counsel, Corporate Secretary: Sheila Denton
Executive Vice President, General Manager, Europe: Jonathan Dickinson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$13.6B
Revenue (TTM)	$4.1B
Shares Outstanding	192.7M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.68
EPS	$0.14
Book Value	$23.14
P/E Ratio	512.5x
Price/Sales (TTM)	3.3
Price/Cash Flow (TTM)	112.3x
Operating Margin	-1.30%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Incyte Corp
NASDAQ:INCYUnited States

Search Criteria

Charts

Recent News

Yesterday

INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investment, from 7:31AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 19, 2024

Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation, from 4:30PM ET on Tuesday Nov 19, 2024 by Dow Jones

DJ Incyte Is the S&P 500's Worst Performer Today. What's Hitting the Stock. -- Barrons.com, from 12:21PM ET on Tuesday Nov 19, 2024 by Dow Jones

DJ Incyte Is Maintained at Sector Perform by RBC Capital, from 10:52AM ET on Tuesday Nov 19, 2024 by Dow Jones

DJ Incyte Down Over 10%, on Pace for Largest Percent Decrease Since April 2018 -- Data Talk, from 10:13AM ET on Tuesday Nov 19, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar